Slide Insurance Holdings, Inc. SLDE ← Back to all reports

Slide Insurance Holdings, Inc.

SLDE · Financials
A ★★★★ Buy
Aug 25, 2026 · Score 85 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $23.52
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $21.50 ($21.00–$22.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $29.86
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+27.0%

Type A - Slide Insurance Holdings, Inc. (SLDE) 20260825 Stock Analysis

📅 Slide Key Upcoming Events

🏢 Step 1: Slide Company Overview & Business Model

Q1-A1. What is Slide?

Q1-A2. How Does Slide Make Money?

Q1-A3. Slide’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Slide’s Competitors?

Q1-A5. Slide Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Slide’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Slide Have a Durable Economic Moat?

Q2-A2. Is Slide’s Growth Sustainable?

Q2-A3. How Does Slide Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Slide Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Slide? (Margins & ROIC)

Q3-A3. What Drives Slide’s Returns? (ROIC Breakdown)

Q3-A4. Are Slide’s Earnings High Quality?

Q3-A5. Is Slide’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Slide Forensic Accounting & Dilution Review

Q4-A1. Does Slide Have Accounting Red Flags?

Q4-A2. Is Slide Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Slide’s Cash Flow?

Q4-A4. Is Slide Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Slide Management & Shareholder Alignment

Q5-A1. Can You Trust Slide’s Management? (Guidance Track Record)

Q5-A2. What Are Slide Insiders Doing?

Q5-A3. Is Slide’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Slide Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Slide Guidance

Q6-A2. What Is Slide’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Slide Catalysts & Price Triggers

Q7-A1. What Could Move Slide Stock? (Top 3 Catalysts)

Q7-A2. Slide’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Slide Fairly Valued? Valuation Analysis

Q8-A1. Slide’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Slide vs Peers: Valuation Comparison

Q8-A3. Is Slide Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Slide? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Slide? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Slide’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Slide? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Slide?

Q9-A2. How Sensitive Is Slide to the Economy?

Q9-A3. Slide Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Slide Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Slide? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Slide’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Slide’s Heavy Concentration in Florida Coastal Property Its Biggest Weakness?

Q2: Can Slide’s 5.7x Forward P/E Be Justified Amidst Hurricane Season Uncertainty?

Q3: How Does the $5.46 Billion Reinsurance Tower Protect Slide’s Balance Sheet?

Q4: Are the Recent Citizens Depopulation Assumptions Driving Sustainable Premium Growth?

Q5: Can the Expansion into California, New York, and New Jersey Diversify Slide’s Risk Profile?

Q6: How Does the 38.0% Q4 2025 Combined Ratio Compare to Industry Standards?

Q7: Will the Newly Initiated Quarterly Dividend Limit Slide’s Reinvestment Capabilities?

Q8: Does the High Insider Ownership and Aggressive Share Repurchase Align with Minority Shareholders?

Q9: How Vulnerable Is Slide to Surges in Reinsurance True-Up Costs if Growth Exceeds Projections?

Q10: What Role Does Proprietary Artificial Intelligence Play in Slide’s Exceptional Loss Ratios?